State Health Policy Blog

Last week, California enacted the first-in-the-nation state law to combat pay-for-delay deals between brand-name and generic pharmaceutical drug manufacturers. In a pay-for-delay deal, a brand manufacturer pays a generic competitor to settle patent litigation and keep the lower-cost version of the drug off the market. Delaying market entry of generic drugs limits competition and can […]

Read More
  • State Health Policy Blog

    Q&A: How Maryland Uses Multiple Policy Levers to Improve Health Coverage, Affordability, and Access

    Maryland has a long history of enacting statewide health reforms and 2019 was no exception with the passage of several significant reforms, including the Maryland Easy Enrollment Health Insurance Program (MEEHP), which passed with bipartisan support and was signed by Gov. Larry Hogan in June. Maryland is also implementing a new value-based plan design for health insurance marketplace plans and […]

    Read More
  • State Health Policy Blog

    State Policy Innovations to Support Family Caregivers

    As the country ages, states recognize the importance of caregivers and are developing new initiatives to support and sustain their critical role in helping relatives, friends, and neighbors age in place. The recent passage of the Recognize, Assist, Include, Support, and Engage Family Caregivers (RAISE) Act, a federal strategy to support family caregivers, brings new […]

    Read More
  • State Health Policy Blog

    State Insurance Reforms Tackle Price Transparency, Rising Costs, and the Uninsured

    September was a busy time for state insurance regulators as they worked to finalize rate filings and prepare for the upcoming health insurance open enrollment season. While initial filings indicate nominal increases to individual market premiums for the 2020 plan year, insurance costs are escalating for individuals and families who receive coverage through their employers.   […]

    Read More
    October 8, 2019 | Filed under: Front Page, State Exchanges, State Health Policy Blog

  • State Health Policy Blog

    Nevada Fines Rx Manufacturers $17.4 Million for Failing to Explain Diabetes Medications’ Price Hikes

    Last week, Nevada fined 21 pharmaceutical companies $17.4 million for failing to submit a report explaining recent, significant price hikes to essential diabetes drugs, as required by the state’s drug cost transparency law. Faced with drug price increases far outpacing rates of inflation, states across the country are enacting transparency laws designed to shed light […]

    Read More
  • State Health Policy Blog

    States Explore Emerging Evidence to Learn New, Innovative Uses of Telehealth

    The National Academy for State Health Policy (NASHP) recently launched the Telehealth Affinity Group, composed of state policymakers, that is examining emerging evidence from the Patient-Centered Outcomes Research Institute (PCORI) into innovative uses of telehealth to transform health care delivery systems in states. State and federal policymakers are eager to explore emerging patient-centered outcomes research […]

    Read More
  • State Health Policy Blog

    State-based Marketplace Leaders Share their Success and Growth with Federal Leaders

    State-based marketplace (SBM) leaders convened in Washington, DC last week to share experiences and ideas and meet with key Congressional staff in advance of this year’s open enrollment period. SBMs, which exercise total control over their health insurance marketplaces in contrast to states that use the federal marketplace, are making considerable progress in reaching and […]

    Read More
    September 23, 2019 | Filed under: Front Page, Insurance Exchanges, State Health Policy Blog

  • State Health Policy Blog

    Legal Landmines in Drug Pricing Laws: What’s a State To Do?

    Every state in the nation has proposed bills to limit pharmaceutical drug prices and the pace of that legislative work increases each year. The usual responses from pharmaceutical manufacturers and their allies is to threaten to reduce their investments in new drug research and development and challenge the new state laws in federal court. In […]

    Read More
  • State Health Policy Blog

    Implementing Rx Drug Transparency: States Are Shining a Light on High-Cost Drugs and their Impact on Premiums

    As health plans prepare to submit rate filings, a new report from Oregon’s Division of Financial Regulation’s Prescription Drug Price Transparency Program illuminates just how much prescription drug prices impact insurance premiums. To increase health care cost transparency, Oregon requires health insurance companies to report on the impact of prescription drug prices on insurance plan […]

    Read More
  • State Health Policy Blog

    Multiple Factors Appear to Be Contributing to Children’s Rising Uninsured Rates

    US Census Bureau data released this past week revealed 8.5 percent (27.5 million people) did not have health coverage at any point during 2018 – an increase from 7.9 percent (25.6 million people) in 2017. The latest census data also affirmed fears raised after reports of declining child enrollment in Medicaid and the Children’s Health […]

    Read More